Related Experiment Video

Updated: Aug 10, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

Prevention of sudden cardiac death

J J Goldberger1

  • 1Division of Cardiology, Department of Medicine, Wesley Pavilion, Northwestern University Memorial Hospital, 250 E. Superior Street, Chicago, IL 60611, USA.

Heart Disease (Hagerstown, Md.)
|December 1, 2001
PubMed

Insights

Sudden cardiac death prevention strategies have advanced, with implantable cardioverter-defibrillators recommended for high-risk patients. Beta-blockers aid survival post-myocardial infarction and in heart failure, while antiarrhythmics show limited prophylactic benefit.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Electrophysiology

Background:

  • Sudden cardiac death (SCD) remains a significant cause of mortality.
  • Recent advancements offer improved treatment and prevention strategies.
  • Identifying at-risk populations is crucial for effective intervention.

Purpose of the Study:

  • To review current strategies for the treatment and prevention of sudden cardiac death.
  • To evaluate the efficacy of various therapeutic approaches, including device-based and pharmacologic therapies.
  • To highlight the importance of risk stratification in guiding prophylactic interventions.

Main Methods:

  • Review of large-scale clinical trials and evidence-based guidelines.
  • Analysis of data on implantable cardioverter-defibrillators (ICDs) for secondary and primary prevention.
  • Evaluation of pharmacologic therapies, including beta-blockers and antiarrhythmic drugs.

Main Results:

  • Implantable cardioverter-defibrillators are the current therapy of choice for patients with sustained ventricular tachyarrhythmia.
  • Beta-blockers demonstrate efficacy in improving survival after myocardial infarction and in patients with congestive heart failure.
  • Antiarrhythmic drugs have not shown efficacy in reducing mortality for prophylactic use in these patient groups.

Conclusions:

  • Implantable cardioverter-defibrillators are highly effective for preventing sudden cardiac death in high-risk individuals.
  • Prophylactic use of ICDs should be reserved for carefully selected high-risk populations.
  • Further research is necessary to precisely define criteria for identifying patients who would benefit most from prophylactic ICD implantation.

More Related Videos

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...